AIMS
Doxorubicin-induced cardiotoxicity (DIC) is a significant cause of
mortality in cancer care. This study was conducted to establish the
frequency of DIC in Zimbabwean breast cancer patients on doxorubicin and
to test the DIC predictive power of genetic biomarkers.